IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 42 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,669,648 | +81.7% | 301,920 | +109.9% | 0.02% | +90.0% |
| Q2 2023 | $8,624,287 | +81.2% | 143,834 | +49.4% | 0.01% | +66.7% |
| Q1 2023 | $4,758,748 | -10.2% | 96,253 | +3.6% | 0.01% | -14.3% |
| Q4 2022 | $5,302,145 | +43.8% | 92,906 | +15.5% | 0.01% | +40.0% |
| Q3 2022 | $3,686,000 | +259.3% | 80,406 | +192.3% | 0.01% | +400.0% |
| Q2 2022 | $1,026,000 | +24.8% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $822,000 | -12.7% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $942,000 | -7.6% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,020,000 | +13.3% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $900,000 | -23.1% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,171,000 | – | 27,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |